Reinier de Graaf serves a population that is aging and expected to grow by 14% through 2030 - with 2 out of 5 people projected to suffer from one or more chronic diseases.
"The hospital's diagnostic capabilities will have to adapt accordingly", says Irma van Gelderen, Manager of Radiology, Nuclear Medicine, Clinical Physics and Urology at Reinier de Graaf. "We are already seeing a yearly 10 to 15% increase in demand for nuclear medical studies such as PET/CT. And in general, imaging studies are getting more complex because people often have multiple conditions."
Stefan Kroese, Director of Operations at Reinier de Graaf, adds: "To offer patients the best possible care, we want state-of-the art equipment. At the same time, we have to invest responsibly. Financial stability and continuity are vital for the future of our hospital. That is why we were looking for a long-term strategic partner." It is a sentiment that is echoed by Rene Dallinga, radiologist at Reinier de Graaf. "It is important for us that we continually have access to the latest innovations, without having to worry about the procurement of each individual piece of equipment."